Aleve
- Product NDC
- 70264-011
- 11-digit product format
- 702640011
- Labeler code
- 70264
- Product ID
- 70264-011_43c866a6-dc20-5e19-e063-6294a90aac20
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- R J General Corporation
- Application
- NDA020204
- Marketing category
- NDA
- Marketing start
- 2014-02-26
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aleve
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAPROXEN SODIUM | 220 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9TN87S3A3C |
| Rxcui | 849574, 849728 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70264-011-01 | Aleve | 50 in 1 CARTON | TABLET | 50 | | 8 |
| 70264-011-01 | Aleve | 1 in 1 POUCH | TABLET | 1 | | 8 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70264-011 | ALEVE (NAPROXEN SODIUM) TABLET [R J GENERAL CORPORATION] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241112_46e7b298-9e19-49b6-be71-e4fdcb09a5d4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70264-011-01 | 70264001101 | 50 POUCH in 1 CARTON (70264-011-01) / 1 TABLET in 1 POUCH | 50 pouch | 2014-02-26 | 0000-00-00 | No | No | Current |